Point72 Asia Singapore Pte. Ltd. Makes New $70,000 Investment in ICU Medical, Inc. (NASDAQ:ICUI)

Point72 Asia Singapore Pte. Ltd. acquired a new stake in ICU Medical, Inc. (NASDAQ:ICUI) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund acquired 590 shares of the medical instruments supplier’s stock, valued at approximately $70,000.

Other institutional investors have also modified their holdings of the company. Vanguard Group Inc. lifted its position in ICU Medical by 14.8% during the fourth quarter. Vanguard Group Inc. now owns 2,440,729 shares of the medical instruments supplier’s stock valued at $243,438,000 after buying an additional 315,103 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in shares of ICU Medical by 539.1% in the fourth quarter. The Manufacturers Life Insurance Company now owns 177,009 shares of the medical instruments supplier’s stock worth $17,655,000 after buying an additional 149,313 shares during the last quarter. Silvercrest Asset Management Group LLC raised its holdings in ICU Medical by 109.4% in the first quarter. Silvercrest Asset Management Group LLC now owns 278,436 shares of the medical instruments supplier’s stock valued at $29,882,000 after acquiring an additional 145,485 shares in the last quarter. Mesirow Institutional Investment Management Inc. bought a new position in ICU Medical during the 1st quarter valued at $15,425,000. Finally, Victory Capital Management Inc. grew its holdings in ICU Medical by 2,966.3% during the 2nd quarter. Victory Capital Management Inc. now owns 141,848 shares of the medical instruments supplier’s stock worth $16,844,000 after acquiring an additional 137,222 shares in the last quarter. Hedge funds and other institutional investors own 96.10% of the company’s stock.

ICU Medical Trading Up 1.3 %

ICU Medical stock opened at $179.20 on Friday. ICU Medical, Inc. has a 1 year low of $78.28 and a 1 year high of $188.53. The firm’s 50-day moving average is $159.14 and its 200-day moving average is $126.07. The company has a debt-to-equity ratio of 0.76, a quick ratio of 1.08 and a current ratio of 2.41. The company has a market cap of $4.37 billion, a P/E ratio of -73.14 and a beta of 0.66.

ICU Medical (NASDAQ:ICUI) last issued its earnings results on Wednesday, August 7th. The medical instruments supplier reported $1.56 EPS for the quarter, beating analysts’ consensus estimates of $1.00 by $0.56. The company had revenue of $596.50 million during the quarter, compared to the consensus estimate of $556.64 million. ICU Medical had a positive return on equity of 5.01% and a negative net margin of 3.07%. ICU Medical’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.58 earnings per share. On average, equities analysts expect that ICU Medical, Inc. will post 3.76 earnings per share for the current year.

Insider Activity at ICU Medical

In other ICU Medical news, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $144.11, for a total value of $295,425.50. Following the sale, the vice president now directly owns 4,482 shares in the company, valued at approximately $645,901.02. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other news, VP Virginia Ruth Sanzone sold 2,050 shares of the firm’s stock in a transaction on Thursday, August 8th. The stock was sold at an average price of $144.11, for a total transaction of $295,425.50. Following the transaction, the vice president now directly owns 4,482 shares of the company’s stock, valued at approximately $645,901.02. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Vivek Jain sold 12,000 shares of the business’s stock in a transaction that occurred on Tuesday, October 1st. The stock was sold at an average price of $178.46, for a total value of $2,141,520.00. Following the sale, the chief executive officer now directly owns 104,593 shares in the company, valued at approximately $18,665,666.78. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 40,552 shares of company stock worth $6,679,322 in the last 90 days. 6.70% of the stock is currently owned by company insiders.

Analysts Set New Price Targets

Several research firms have recently weighed in on ICUI. KeyCorp boosted their target price on shares of ICU Medical from $136.00 to $147.00 and gave the stock an “overweight” rating in a research report on Thursday, August 8th. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Thursday, August 8th. StockNews.com upgraded ICU Medical from a “hold” rating to a “buy” rating in a research note on Thursday, September 12th. Finally, Raymond James lifted their target price on ICU Medical from $158.00 to $190.00 and gave the stock an “outperform” rating in a research report on Thursday, September 12th. One research analyst has rated the stock with a hold rating and four have issued a buy rating to the company. Based on data from MarketBeat, ICU Medical presently has an average rating of “Moderate Buy” and a consensus price target of $149.00.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.